MarketPulse
C

$CGC

9 articles found
0 positive
5 negative
4 neutral
The Motley FoolThe Motley Fool··Motley Fool Youtube

Cannabis Tax Overhaul Creates Winners, Losers: Medical Operators Gain as MSOs Face Headwinds

Federal cannabis tax reforms introduce split schedule favoring medical-only operators while creating compliance burdens for multi-state operators, reshaping sector dynamics.
CGCcash flowmargins
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

Canopy Growth's 25% Rally Masks Deeper Problems—Is This Recovery Real?

Canopy Growth's 25% monthly rally may be a dead cat bounce. Despite debt reduction and acquisition efforts, the company remains unprofitable since 2017 amid regulatory pressures and illicit market competition.
CGCshareholder dilutionprofitability concerns
The Motley FoolThe Motley Fool··Thomas Niel

Canopy Growth's 99.6% Collapse: Structural Decay or Contrarian Opportunity?

Canopy Growth collapsed 99.6% due to persistent losses, regulatory barriers, and cash burn. Analyst recommend stronger alternatives like Green Thumb Industries.
CGCCRONstock declineshareholder dilution
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

Canopy Growth's 99% Collapse Raises Hard Questions for Remaining Shareholders

Cannabis leader $CGC has crashed 99% from $568 peak to ~$1, facing profitability challenges and dilutive acquisition amid intense competition.
CGCstock declineacquisition
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

From $300 to Pennies: Can Canopy Growth Survive Its Existential Crisis?

Canopy Growth stock has crashed 99% from $300 to under $2, posting weak financials and facing structural industry headwinds despite U.S. cannabis reclassification.
CGCstock declinefree cash flow
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

Canopy Growth's Dramatic Collapse: Evaluating Investor Options in Distressed Cannabis Stock

Canopy Growth stock collapsed 99.8% to penny-stock status amid operational losses and sector cooling. Investors face potential tax-loss harvesting strategies rather than speculative recovery bets.
CGCshareholder dilutionmarijuana stocks
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Tilray and Canopy Growth Navigate Evolving Cannabis Market Landscape

Tilray and Canopy Growth strengthen positions amid shifting U.S. cannabis regulations. Both improve financials, with Tilray offering broader geographic diversification versus Canopy's focused approach.
CGCTLRYCanopy Growthcannabis stocks
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Cannabis Market Set to Reach $3.32B by 2030 as Premium Innovation Accelerates

Cannabis market projected to grow from $2.24B in 2025 to $3.32B by 2030, driven by legalization, premium products, and innovation in consumption methods.
CGCACBTLRYCRONSNDLmarket growthproduct innovation
BenzingaBenzinga··Prnewswire

MTL Cannabis Shareholders Overwhelmingly Back Canopy Growth Acquisition Deal

MTL Cannabis shareholders overwhelmingly approve Canopy Growth acquisition with 99.97% support. Court approval expected February 23, 2026, with closing targeted before March 2026.
CGCacquisitionmerger